Reuters logo
L'Oreal/Nestle venture sweetens Q-med bid
February 10, 2011 / 7:43 AM / 7 years ago

L'Oreal/Nestle venture sweetens Q-med bid

STOCKHOLM (Reuters) - The L‘Oreal (OREP.PA) and Nestle NESN.VX joint venture Galderma said on Thursday it was raising its bid for Swedish beauty treatments firm Q-Med QMED.ST by about 5 percent.

Galderma raised its bid to 79 crowns per share, valuing the company at $1.16 billion. Earlier this week, Galderma said its 75 crown per share bid had fallen well short of a target for 90 acceptances.

Galderma said owners holding just under 78 percent of shares had agreed to accept the raised offer.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below